Changes in Beneficial Ownership · 4
UroGen Pharma Ltd.
URGNNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
rdgdoc.xml
Filing details
- Report period
- 2026-06-22
- Issuer
- UroGen Pharma Ltd.
- Issuer CIK
- 0001668243
- Trading symbol
- URGN
Reporting owner 1
- Name
- BUTITTA CYNTHIA M
- Reporting owner CIK
- 0001222082
- Relationship
- Director
- Address
- 400 ALEXANDER PARK DRIVE, PRINCETON, NJ, 08540
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right ot buy) | 34.99 | 2026-06-22 | A · Form 4 | 10,000 | A | 0 | [F1] | 2036-06-22 | Ordinary Shares | 10,000 | 10,000 | D |
| Restricted Stock Unit | [F2] | 2026-06-22 | A · Form 4 | 8,000 | A | 0 | [F3] | [F3] | Ordinary Shares | 8,000 | 8,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.↩ 1
- F2
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer↩ 1
Signature 1
- Signed
- /s/ Jason D. Smith, Attorney-in-Fact
- Date
- 2026-06-23